NO326247B1 - Fremgangsmate for fremstilling av modent insulin eller et modent insulin derivat. - Google Patents
Fremgangsmate for fremstilling av modent insulin eller et modent insulin derivat. Download PDFInfo
- Publication number
- NO326247B1 NO326247B1 NO20014815A NO20014815A NO326247B1 NO 326247 B1 NO326247 B1 NO 326247B1 NO 20014815 A NO20014815 A NO 20014815A NO 20014815 A NO20014815 A NO 20014815A NO 326247 B1 NO326247 B1 NO 326247B1
- Authority
- NO
- Norway
- Prior art keywords
- carboxypeptidase
- precursor form
- natural
- isoform
- sequence
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 31
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title claims description 48
- 102000004877 Insulin Human genes 0.000 title claims description 20
- 108090001061 Insulin Proteins 0.000 title claims description 20
- 229940125396 insulin Drugs 0.000 title claims description 20
- 239000004026 insulin derivative Substances 0.000 title claims description 9
- 108090000087 Carboxypeptidase B Proteins 0.000 claims abstract description 88
- 102000003670 Carboxypeptidase B Human genes 0.000 claims abstract description 88
- 239000002243 precursor Substances 0.000 claims abstract description 33
- 102000001708 Protein Isoforms Human genes 0.000 claims abstract description 19
- 108010029485 Protein Isoforms Proteins 0.000 claims abstract description 19
- 230000028327 secretion Effects 0.000 claims abstract description 10
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 9
- 102100035024 Carboxypeptidase B Human genes 0.000 claims abstract description 8
- 101000946524 Homo sapiens Carboxypeptidase B Proteins 0.000 claims abstract description 8
- 244000005700 microbiome Species 0.000 claims abstract description 8
- 108090000631 Trypsin Proteins 0.000 claims description 20
- 102000004142 Trypsin Human genes 0.000 claims description 20
- 239000012588 trypsin Substances 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 17
- 150000001413 amino acids Chemical class 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 12
- 241000235058 Komagataella pastoris Species 0.000 claims description 8
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 5
- 238000011097 chromatography purification Methods 0.000 claims description 5
- 108020001507 fusion proteins Proteins 0.000 claims description 5
- 102000037865 fusion proteins Human genes 0.000 claims description 5
- 102000005593 Endopeptidases Human genes 0.000 claims description 4
- 108010059378 Endopeptidases Proteins 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- 230000003248 secreting effect Effects 0.000 claims description 4
- 108090000317 Chymotrypsin Proteins 0.000 claims description 3
- 108060005980 Collagenase Proteins 0.000 claims description 3
- 102000029816 Collagenase Human genes 0.000 claims description 3
- 108010074860 Factor Xa Proteins 0.000 claims description 3
- 108010067372 Pancreatic elastase Proteins 0.000 claims description 3
- 102000016387 Pancreatic elastase Human genes 0.000 claims description 3
- 229960002376 chymotrypsin Drugs 0.000 claims description 3
- 229960002424 collagenase Drugs 0.000 claims description 3
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 abstract description 5
- 102000039446 nucleic acids Human genes 0.000 abstract description 5
- 150000007523 nucleic acids Chemical class 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 description 24
- 102000004169 proteins and genes Human genes 0.000 description 22
- 108091028043 Nucleic acid sequence Proteins 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 10
- 239000002299 complementary DNA Substances 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 238000003752 polymerase chain reaction Methods 0.000 description 7
- 238000007792 addition Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 102000005367 Carboxypeptidases Human genes 0.000 description 5
- 108010006303 Carboxypeptidases Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 108010076181 Proinsulin Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 238000011537 Coomassie blue staining Methods 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 210000004923 pancreatic tissue Anatomy 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000018389 Exopeptidases Human genes 0.000 description 1
- 108010091443 Exopeptidases Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 241000866625 Polymorphus Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 108010034416 glutarylamidocephalosporanic acid acylase Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical group C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007169 ligase reaction Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000013014 purified material Substances 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 239000012465 retentate Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19915938A DE19915938A1 (de) | 1999-04-09 | 1999-04-09 | Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung |
| PCT/EP2000/002571 WO2000061727A2 (fr) | 1999-04-09 | 2000-03-23 | Production de procarboxypeptidase b pancreatique, de ses isoformes et muteines et leur utilisation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20014815D0 NO20014815D0 (no) | 2001-10-03 |
| NO20014815L NO20014815L (no) | 2001-11-20 |
| NO326247B1 true NO326247B1 (no) | 2008-10-27 |
Family
ID=7903951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20014815A NO326247B1 (no) | 1999-04-09 | 2001-10-03 | Fremgangsmate for fremstilling av modent insulin eller et modent insulin derivat. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6531294B1 (fr) |
| EP (1) | EP1169461B1 (fr) |
| JP (1) | JP2002541793A (fr) |
| KR (1) | KR100714116B1 (fr) |
| CN (1) | CN100362105C (fr) |
| AT (1) | ATE341630T1 (fr) |
| AU (1) | AU777408B2 (fr) |
| BR (1) | BR0009636B1 (fr) |
| CA (1) | CA2369973C (fr) |
| DE (2) | DE19915938A1 (fr) |
| ES (1) | ES2270827T3 (fr) |
| HK (1) | HK1044566B (fr) |
| IL (2) | IL145646A0 (fr) |
| NO (1) | NO326247B1 (fr) |
| NZ (1) | NZ514657A (fr) |
| WO (1) | WO2000061727A2 (fr) |
| ZA (1) | ZA200108241B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7291587B2 (en) | 2001-11-09 | 2007-11-06 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides |
| ES2337684T3 (es) * | 2003-12-05 | 2010-04-28 | F. Hoffmann-La Roche Ag | Carboxipeptidasa b recombinante y su purificacion. |
| EP1538203B1 (fr) * | 2003-12-05 | 2010-01-20 | Roche Diagnostics GmbH | Carboxypeptidase B recombinante et sa purification |
| JP5114201B2 (ja) * | 2004-09-27 | 2013-01-09 | サノフイ−アベンテイス・ドイチユラント・ゲー・エム・ベー・ハー | 組み換えカルボキシペプチダーゼｂ |
| ES2425413T3 (es) * | 2006-11-22 | 2013-10-15 | Novo Nordisk A/S | Método para preparar carboxipeptidasa activada |
| CN101058805B (zh) * | 2007-03-21 | 2011-09-07 | 北京贯虹科技有限公司 | 突变羧肽酶原b及突变羧肽酶b的生产方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE58906966D1 (de) | 1988-06-23 | 1994-03-24 | Hoechst Ag | Mini-Proinsulin, seine Herstellung und Verwendung. |
| IL95495A (en) | 1989-08-29 | 1996-10-16 | Hoechst Ag | Fusion proteins their preparation and use |
| JP2660095B2 (ja) * | 1989-10-31 | 1997-10-08 | シェリング・コーポレーション | 大腸菌分泌性株 |
| DE4009268A1 (de) | 1990-03-22 | 1991-09-26 | Consortium Elektrochem Ind | Sekretion von hirudinderivaten |
| FI103805B (fi) * | 1990-09-05 | 1999-09-30 | Hoechst Ag | Menetelmä preproinsuliinien hydroloimiseksi |
| DE4136389A1 (de) | 1991-03-18 | 1992-10-08 | Hoechst Ag | Verfahren zur herstellung von glutarylacylase in grossen mengen |
| CA2175834A1 (fr) * | 1993-11-16 | 1995-05-26 | Jeffrey Tobin Fayerman | Sequences d'adn codant la carboxypeptidase b pancreatique porcine |
| US5658755A (en) | 1994-07-15 | 1997-08-19 | Eli Lilly And Company | Method for extra-cellular expression of protein |
| IL116696A (en) | 1995-01-25 | 1999-08-17 | Bio Technology General Corp | Production of enzymatically active recombinant carboxypeptidase b |
-
1999
- 1999-04-09 DE DE19915938A patent/DE19915938A1/de not_active Ceased
-
2000
- 2000-03-22 US US09/532,730 patent/US6531294B1/en not_active Expired - Lifetime
- 2000-03-23 EP EP00926751A patent/EP1169461B1/fr not_active Expired - Lifetime
- 2000-03-23 AU AU45394/00A patent/AU777408B2/en not_active Ceased
- 2000-03-23 AT AT00926751T patent/ATE341630T1/de active
- 2000-03-23 WO PCT/EP2000/002571 patent/WO2000061727A2/fr active IP Right Grant
- 2000-03-23 IL IL14564600A patent/IL145646A0/xx active IP Right Grant
- 2000-03-23 NZ NZ514657A patent/NZ514657A/en not_active IP Right Cessation
- 2000-03-23 DE DE50013563T patent/DE50013563D1/de not_active Expired - Lifetime
- 2000-03-23 BR BRPI0009636-9A patent/BR0009636B1/pt not_active IP Right Cessation
- 2000-03-23 CN CNB008060800A patent/CN100362105C/zh not_active Expired - Fee Related
- 2000-03-23 KR KR1020017012888A patent/KR100714116B1/ko not_active IP Right Cessation
- 2000-03-23 JP JP2000611652A patent/JP2002541793A/ja active Pending
- 2000-03-23 ES ES00926751T patent/ES2270827T3/es not_active Expired - Lifetime
- 2000-03-23 CA CA2369973A patent/CA2369973C/fr not_active Expired - Lifetime
-
2001
- 2001-09-25 IL IL145646A patent/IL145646A/en not_active IP Right Cessation
- 2001-10-03 NO NO20014815A patent/NO326247B1/no not_active IP Right Cessation
- 2001-10-08 ZA ZA200108241A patent/ZA200108241B/xx unknown
-
2002
- 2002-08-22 HK HK02106158.3A patent/HK1044566B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100714116B1 (ko) | 2007-05-07 |
| WO2000061727A2 (fr) | 2000-10-19 |
| CA2369973A1 (fr) | 2000-10-19 |
| BR0009636A (pt) | 2002-01-08 |
| IL145646A0 (en) | 2002-06-30 |
| US6531294B1 (en) | 2003-03-11 |
| NZ514657A (en) | 2003-11-28 |
| WO2000061727A3 (fr) | 2001-02-01 |
| CN1346407A (zh) | 2002-04-24 |
| AU4539400A (en) | 2000-11-14 |
| AU777408B2 (en) | 2004-10-14 |
| ATE341630T1 (de) | 2006-10-15 |
| EP1169461B1 (fr) | 2006-10-04 |
| DE19915938A1 (de) | 2000-10-19 |
| CN100362105C (zh) | 2008-01-16 |
| HK1044566A1 (en) | 2002-10-25 |
| BR0009636B1 (pt) | 2010-11-16 |
| DE50013563D1 (de) | 2006-11-16 |
| EP1169461A2 (fr) | 2002-01-09 |
| NO20014815L (no) | 2001-11-20 |
| JP2002541793A (ja) | 2002-12-10 |
| NO20014815D0 (no) | 2001-10-03 |
| KR20010109348A (ko) | 2001-12-08 |
| HK1044566B (zh) | 2008-08-01 |
| CA2369973C (fr) | 2011-09-27 |
| ES2270827T3 (es) | 2007-04-16 |
| IL145646A (en) | 2008-03-20 |
| ZA200108241B (en) | 2002-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR920007666B1 (ko) | 변형된 섬유소 용해제의 제조방법 | |
| AU2002231784B2 (en) | Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture | |
| NO311142B1 (no) | Fusjonerte proteiner og fremgangsmåte for enzymatisk spalting av rekombinante proteiner ved anvendelse av IgA-proteaser ogfremgangsmåte for fremstilling av rekombinant G-CSF | |
| WO1992006211A1 (fr) | Procede pour produire un peptide ou une proteine | |
| JPH01199578A (ja) | Ｋｅｘ２エンドプロテアーゼ及びその製造方法 | |
| CA2613471A1 (fr) | Lignees cellulaires permettant d'exprimer une enzyme utile pour la preparation de produits amides | |
| KR100858833B1 (ko) | 효모에 의해 분비되는 재조합 단백질의 제조를 위한,ｎ-말단 부분이 히루딘 유도체인 융합 단백질의 용도 | |
| EP1364030B1 (fr) | Peptides aptes a l'hypersecretion, procedes permettant leur production, et l'amelioration en parallele des formes exportees d'un ou de plusieurs polypeptides d'interet | |
| KR20100086717A (ko) | 대장균에서 외래단백질을 분비 생산하는 방법 | |
| NO326247B1 (no) | Fremgangsmate for fremstilling av modent insulin eller et modent insulin derivat. | |
| KR100659671B1 (ko) | 신규한 융합단백질로부터 재조합 인슐린을 제조하는 방법 | |
| CN109136209B (zh) | 肠激酶轻链突变体及其应用 | |
| US6428997B1 (en) | Aminopeptidase derived from Bacillus licheniformis and process for preparation of natural type proteins | |
| MXPA01009979A (en) | Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use | |
| JP2005503141A (ja) | アシル化ポリペプチドを作出するための方法 | |
| JP2003079379A (ja) | 成長ホルモンの高発現用ｄｎａおよびその使用 | |
| RU2451076C1 (ru) | СПОСОБ ПОЛУЧЕНИЯ ПРОТЕИНАЗЫ Ulp275 | |
| KR20090003652A (ko) | 인간 기질 세포 유도체의 수용성 단백질로의 재생 방법 | |
| JPH02186988A (ja) | 抗ウイルス性タンパク質の製造方法 | |
| KR20150089499A (ko) | 대량 생산이 가능하도록 개선된 경구투여용 트롬보포이에틴 및 이의 대량 생산공정 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |